{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T05:16:32Z","timestamp":1740114992503,"version":"3.37.3"},"reference-count":37,"publisher":"Elsevier BV","issue":"31","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Ministry of Agriculture of China","award":["2009ZX08006-001B"],"award-info":[{"award-number":["2009ZX08006-001B"]}]},{"name":"National Science and Technology for the Rural Development in China","award":["2011AA100305-2"],"award-info":[{"award-number":["2011AA100305-2"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["30771615","30300258"],"award-info":[{"award-number":["30771615","30300258"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.vaccine.2015.05.045","type":"journal-article","created":{"date-parts":[[2015,5,31]],"date-time":"2015-05-31T11:47:27Z","timestamp":1433072847000},"page":"3758-3765","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["A broad protection provided by matrix protein 2 (M2) of avian influenza virus"],"prefix":"10.1016","volume":"33","author":[{"given":"Qingwen","family":"Meng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangliang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonggang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxia","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kehui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangdong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongwei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.05.045_bib0190","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1128\/JVI.62.8.2762-2772.1988","article-title":"A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions","volume":"62","author":"Zebedee","year":"1988","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.05.045_bib0195","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1743-422X-3-102","article-title":"Influenza A virus infection engenders a poor antibody response against the ectodomain of matrix protein 2","volume":"3","author":"Feng","year":"2006","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2015.05.045_bib0200","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/0092-8674(85)90211-9","article-title":"Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface","volume":"40","author":"Lamb","year":"1985","journal-title":"Cell"},{"key":"10.1016\/j.vaccine.2015.05.045_bib0205","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/330381a0","article-title":"Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein","volume":"330","author":"Clarke","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2015.05.045_bib0210","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.virol.2005.04.004","article-title":"Universal influenza A vaccine: optimization of M2-based constructs","volume":"337","author":"De Filette","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2015.05.045_bib0215","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1016\/j.vaccine.2004.02.021","article-title":"Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeys","volume":"22","author":"Fan","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.05.045_bib0220","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1016\/S0264-410X(03)00040-9","article-title":"Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2","volume":"21","author":"Mozdzanowska","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.05.045_bib0225","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1743-422X-7-9","article-title":"An M2e-based multiple antigenic peptide vaccine protects mice from lethal challenge with divergent H5N1 influenza viruses","volume":"7","author":"Zhao","year":"2010","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2015.05.045_bib0230","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/S0264-410X(99)00005-5","article-title":"Modified M2 proteins produce heterotypic immunity against influenza A virus","volume":"17","author":"Frace","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.05.045_bib0235","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1038\/13484","article-title":"A universal influenza A vaccine based on the extracellular domain of the M2 protein","volume":"5","author":"Neirynck","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2015.05.045_bib0240","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/0264-410X(95)92777-Y","article-title":"Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein","volume":"13","author":"Slepushkin","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.05.045_bib0245","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1073\/pnas.1012199108","article-title":"Vaccination inducing broad and improved cross protection against multiple subtypes of influenza A virus","volume":"108","author":"Song","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2015.05.045_bib0250","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1016\/j.vaccine.2008.12.034","article-title":"Comparative immunogenicity evaluations of influenza A virus M2 peptide as recombinant virus like particle or conjugate vaccines in mice and monkeys","volume":"27","author":"Fu","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.05.045_bib0255","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.vaccine.2007.10.062","article-title":"Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin","volume":"26","author":"Huleatt","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.05.045_bib0260","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0928-8244(03)00009-9","article-title":"N-terminus of M2 protein could induce antibodies with inhibitory activity against influenza virus replication","volume":"35","author":"Liu","year":"2003","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.vaccine.2015.05.045_bib0265","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1006\/viro.1998.9534","article-title":"Treatment of influenza virus-infected SCID mice with nonneutralizing antibodies specific for the transmembrane proteins matrix 2 and neuraminidase reduces the pulmonary virus titer but fails to clear the infection","volume":"254","author":"Mozdzanowska","year":"1999","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2015.05.045_bib0270","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1128\/JVI.64.3.1375-1377.1990","article-title":"Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice","volume":"64","author":"Treanor","year":"1990","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.05.045_bib0275","doi-asserted-by":"crossref","first-page":"3104","DOI":"10.1016\/S0264-410X(02)00266-9","article-title":"A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responses","volume":"20","author":"Jegerlehner","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.05.045_bib0280","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nri2054","article-title":"Scientific barriers to developing vaccines against avian influenza viruses","volume":"7","author":"Subbarao","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2015.05.045_bib0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vetimm.2007.10.019","article-title":"Construction and functional test of a chicken MHC-I (BF2*15)\/peptide tetramer","volume":"122","author":"Liu","year":"2008","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1016\/j.vaccine.2015.05.045_bib0290","doi-asserted-by":"crossref","first-page":"6963","DOI":"10.1128\/JVI.00284-09","article-title":"Primary high-dose murine norovirus 1 infection fails to protect from secondary challenge with homologous virus","volume":"83","author":"Liu","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.05.045_bib0295","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1128\/JCM.39.1.196-200.2001","article-title":"Simultaneous detection of influenza viruses A and B using real-time quantitative PCR","volume":"39","author":"van Elden","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2015.05.045_bib0300","doi-asserted-by":"crossref","first-page":"5158","DOI":"10.1016\/j.vaccine.2006.04.008","article-title":"Protection against H1, H5, H6 and H9 influenza A infection with liposomal matrix 2 epitope vaccines","volume":"24","author":"Ernst","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.05.045_bib0305","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1743-422X-4-118","article-title":"Roles of adjuvant and route of vaccination in antibody response and protection engendered by a synthetic matrix protein 2-based influenza A virus vaccine in the mouse","volume":"4","author":"Mozdzanowska","year":"2007","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2015.05.045_bib0310","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1126\/science.1062882","article-title":"Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses","volume":"293","author":"Hatta","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2015.05.045_bib0315","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nature02746","article-title":"Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia","volume":"430","author":"Li","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2015.05.045_bib0320","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0140-6736(04)15595-5","article-title":"Re-emergence of fatal human influenza A subtype H5N1 disease","volume":"363","author":"Peiris","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.05.045_bib0325","doi-asserted-by":"crossref","first-page":"5656","DOI":"10.1128\/JVI.75.12.5656-5662.2001","article-title":"Influenza A virus can undergo multiple cycles of replication without M2 ion channel activity","volume":"75","author":"Watanabe","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.05.045_bib0330","doi-asserted-by":"crossref","first-page":"6644","DOI":"10.1128\/JVI.79.11.6644-6654.2005","article-title":"Influenza type A virus escape mutants emerge in vivo in the presence of antibodies to the ectodomain of matrix protein 2","volume":"79","author":"Zharikova","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2015.05.045_bib0335","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.micinf.2010.01.001","article-title":"Research and development of universal influenza vaccines","volume":"12","author":"Du","year":"2010","journal-title":"Microb Infect"},{"key":"10.1016\/j.vaccine.2015.05.045_bib0340","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.virusres.2004.02.030","article-title":"A universal human influenza A vaccine","volume":"103","author":"Fiers","year":"2004","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2015.05.045_bib0345","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3201\/eid1303.061125","article-title":"Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1","volume":"13","author":"Tompkins","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2015.05.045_bib0350","doi-asserted-by":"crossref","first-page":"e9809","DOI":"10.1371\/journal.pone.0009809","article-title":"Versatile virus-like particle carrier for epitope based vaccines","volume":"5","author":"Tissot","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2015.05.045_bib0355","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.4049\/jimmunol.173.5.3310","article-title":"The cholera toxin-derived CTA1-DD vaccine adjuvant administered intranasally does not cause inflammation or accumulate in the nervous tissues","volume":"173","author":"Eriksson","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.05.045_bib0360","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.4049\/jimmunol.172.9.5598","article-title":"Influenza A vaccine based on the extracellular domain of M2: weak protection mediated via antibody-dependent NK cell activity","volume":"172","author":"Jegerlehner","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.05.045_bib0365","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/80538","article-title":"Epidermal immunization by a needle-free powder delivery technology: immunogenicity of influenza vaccine and protection in mice","volume":"6","author":"Chen","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2015.05.045_bib0370","doi-asserted-by":"crossref","first-page":"6597","DOI":"10.1016\/j.vaccine.2006.05.082","article-title":"Improved design and intranasal delivery of an M2e-based human influenza A vaccine","volume":"24","author":"De Filette","year":"2006","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15006970?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15006970?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T22:14:05Z","timestamp":1599084845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15006970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":37,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0264410X15006970"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.05.045","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A broad protection provided by matrix protein 2 (M2) of avian influenza virus","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.05.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}